NCT01202890: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer |
|
|
| Terminated | 1 | 1 | US | Lenalidomide, Liposomal Doxorubicin, Bevacizumab, Revlimid, Doxil, Avastin | New Mexico Cancer Care Alliance, Celgene Corporation | Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | 05/11 | 05/12 | | |
